Emma Nilsson1, Ashok Matte1, Alexander Perfilyev1, Vanessa D de Mello1, Pirjo Käkelä1, Jussi Pihlajamäki1, Charlotte Ling1. 1. Epigenetics and Diabetes Unit (E.N., A.P., C.L.), Department of Clinical Sciences, Lund University Diabetes Centre, 205 02 Malmö, Sweden; Department of Clinical Nutrition (A.M., V.D.d.M., J.P.), Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Department of Surgery (P.K.), University of Eastern Finland and Kuopio University Hospital, and Clinical Nutrition and Obesity Center (J.P.), Kuopio University Hospital, 70211 Kuopio, Finland.
Abstract
OBJECTIVE: Epigenetic variation may contribute to the development of complex metabolic diseases such as type 2 diabetes (T2D). Hepatic insulin resistance is a hallmark of T2D. However, it remains unknown whether epigenetic alterations take place in the liver from diabetic subjects. Therefore, we investigated the genome-wide DNA methylation pattern in the liver from subjects with T2D and nondiabetic controls and related epigenetic alterations to gene expression and circulating folate levels. RESEARCH DESIGN AND METHODS: Liver biopsies were obtained from 35 diabetic and 60 nondiabetic subjects, which are part of the Kuopio Obesity Surgery Study. The genome-wide DNA methylation pattern was analyzed in the liver using the HumanMethylation450 BeadChip. RNA expression was analyzed from a subset of subjects using the HumanHT-12 Expression BeadChip. RESULTS: After correction for multiple testing, we identified 251 individual CpG sites that exhibit differential DNA methylation in liver obtained from T2D compared with nondiabetic subjects (Q < .05). These include CpG sites annotated to genes that are biologically relevant to the development of T2D such as GRB10, ABCC3, MOGAT1, and PRDM16. The vast majority of the significant CpG sites (94%) displayed decreased DNA methylation in liver from subjects with T2D. The hypomethylation found in liver from diabetic subjects may be explained by reduced folate levels. Indeed, subjects with T2D had significantly reduced erythrocyte folate levels compared with nondiabetic subjects. We further identified 29 genes that displayed both differential DNA methylation and gene expression in human T2D liver including the imprinted gene H19. CONCLUSIONS: Our study highlights the importance of epigenetic and transcriptional changes in the liver from subjects with T2D. Reduced circulating folate levels may provide an explanation for hypomethylation in the human diabetic liver.
OBJECTIVE: Epigenetic variation may contribute to the development of complex metabolic diseases such as type 2 diabetes (T2D). Hepatic insulin resistance is a hallmark of T2D. However, it remains unknown whether epigenetic alterations take place in the liver from diabetic subjects. Therefore, we investigated the genome-wide DNA methylation pattern in the liver from subjects with T2D and nondiabetic controls and related epigenetic alterations to gene expression and circulating folate levels. RESEARCH DESIGN AND METHODS: Liver biopsies were obtained from 35 diabetic and 60 nondiabetic subjects, which are part of the Kuopio Obesity Surgery Study. The genome-wide DNA methylation pattern was analyzed in the liver using the HumanMethylation450 BeadChip. RNA expression was analyzed from a subset of subjects using the HumanHT-12 Expression BeadChip. RESULTS: After correction for multiple testing, we identified 251 individual CpG sites that exhibit differential DNA methylation in liver obtained from T2D compared with nondiabetic subjects (Q < .05). These include CpG sites annotated to genes that are biologically relevant to the development of T2D such as GRB10, ABCC3, MOGAT1, and PRDM16. The vast majority of the significant CpG sites (94%) displayed decreased DNA methylation in liver from subjects with T2D. The hypomethylation found in liver from diabetic subjects may be explained by reduced folate levels. Indeed, subjects with T2D had significantly reduced erythrocyte folate levels compared with nondiabetic subjects. We further identified 29 genes that displayed both differential DNA methylation and gene expression in human T2D liver including the imprinted gene H19. CONCLUSIONS: Our study highlights the importance of epigenetic and transcriptional changes in the liver from subjects with T2D. Reduced circulating folate levels may provide an explanation for hypomethylation in the humandiabetic liver.
Authors: Jussi Pihlajamäki; Tiina Kuulasmaa; Dorota Kaminska; Marko Simonen; Vesa Kärjä; Sari Grönlund; Pirjo Käkelä; Matti Pääkkönen; Sakari Kainulainen; Kari Punnonen; Johanna Kuusisto; Helena Gylling; Markku Laakso Journal: J Hepatol Date: 2011-10-23 Impact factor: 25.083
Authors: Jussi Pihlajamäki; Sari Grönlund; Marko Simonen; Pirjo Käkelä; Leena Moilanen; Matti Pääkkönen; Elina Pirinen; Marjukka Kolehmainen; Vesa Kärjä; Sakari Kainulainen; Matti Uusitupa; Esko Alhava; Tatu A Miettinen; Helena Gylling Journal: Metabolism Date: 2009-12-16 Impact factor: 8.694
Authors: Anders H Olsson; Petr Volkov; Karl Bacos; Tasnim Dayeh; Elin Hall; Emma A Nilsson; Claes Ladenvall; Tina Rönn; Charlotte Ling Journal: PLoS Genet Date: 2014-11-06 Impact factor: 5.917
Authors: Vanessa D de Mello; Ashok Matte; Alexander Perfilyev; Ville Männistö; Tina Rönn; Emma Nilsson; Pirjo Käkelä; Charlotte Ling; Jussi Pihlajamäki Journal: Epigenetics Date: 2017-02-23 Impact factor: 4.528
Authors: Daniel S Lupu; Luz D Orozco; Ying Wang; John M Cullen; Matteo Pellegrini; Steven H Zeisel Journal: FASEB J Date: 2017-02-08 Impact factor: 5.191
Authors: Karlijn A C Meeks; Peter Henneman; Andrea Venema; Juliet Addo; Silver Bahendeka; Tom Burr; Ina Danquah; Cecilia Galbete; Marcel M A M Mannens; Frank P Mockenhaupt; Ellis Owusu-Dabo; Charles N Rotimi; Matthias B Schulze; Liam Smeeth; Joachim Spranger; Mohammad H Zafarmand; Adebowale Adeyemo; Charles Agyemang Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196
Authors: Laurie K Svoboda; Kari Neier; Kai Wang; Raymond G Cavalcante; Christine A Rygiel; Zing Tsai; Tamara R Jones; Siyu Liu; Jaclyn M Goodrich; Claudia Lalancette; Justin A Colacino; Maureen A Sartor; Dana C Dolinoy Journal: Epigenetics Date: 2020-11-08 Impact factor: 4.528